Login / Signup

The challenge of pharmacological thromboprophylaxis in ICU patients: anti-FXa activity does not constitute the simple solution. Author's reply.

Daniel A HofmaennerMervyn Singer
Published in: Intensive care medicine (2022)
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • intensive care unit
  • prognostic factors
  • venous thromboembolism
  • patient reported outcomes
  • atrial fibrillation